Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers

31 Aug 2022

Abstract excerpt

BACKGROUND: It has become increasingly important to identify molecular markers for accurately diagnosing prostate cancer (PCa) stages between localized PCa (LPC) and locally advanced PCa (LAPC). However, there is a lack of profiling both epigenome-wide DNA methylation and transcriptome for the same patients with PCa at different stages. This study aims to identify epitranscriptomic biomarkers screened in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36057424
DOI: 10.1016/j.ygeno.2022.110474

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markersPMID 36057424Read ↗

Prediction of Prognosis in Patients with Prostate Cancer by DNA Methylation ClassificationSemantic proximity Read ↗

Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.Semantic proximity Read ↗

Integrating Multi-Omics Data to Uncover Prostate Tissue DNA Methylation Biomarkers and Target Genes for Prostate Cancer Risk.Semantic proximity Read ↗

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.Semantic proximity Read ↗

Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate TissuesSemantic proximity Read ↗

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive diseaseSemantic proximity Read ↗

Identification of New Differentially Methylated Genes That Have Potential Functional Consequences in Prostate CancerSemantic proximity Read ↗

Establishing a Prognostic Model in Prostate Adenocarcinoma through Comprehensive scRNA-Seq and Bulk RNA-Seq Analysis and ValidationSemantic proximity Read ↗

Genomic hallmarks of localized, non-indolent prostate cancer.Semantic proximity Read ↗

Subtypes of m6A RNA Modification Defines Tumor Microenvironment, Immunotherapy and Pharmacogenomic Landscape in Prostate CancerSemantic proximity Read ↗

Construction of risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validationSemantic proximity Read ↗

The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.